{"url_path":"/sec/ctso/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1175151/0001104659-26-060270-index.html","accession_number":"0001104659-26-060270","cik":"0001175151","ticker":"CTSO","issuer_name":"Cytosorbents Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/1175151/0001104659-26-060270-index.html","primary_entity_key":"0001175151","primary_entity_name":"Cytosorbents Corp"},"word_count":78,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings.\n\nFrom time to time, we may become involved in litigation or other legal proceedings arising in the ordinary course of business. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact because of defense and settlement costs, diversion of management resources and other factors.\n\n​"}